Shanghai CirCode Biomed Co. Ltd.
PrivateLast Round
Series A
Aug 15, 2023
Company Overview
Shanghai CirCode Biomed Co. Ltd. is a biotechnology company that develops circular RNA (circRNA) therapeutics for cardiovascular diseases, autoimmune disorders, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai CirCode Biomed Co. Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Shanghai CirCode Biomed Co. Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 15, 2023 | ||||
| Pre Seed | Dec 16, 2021 | ||||
| Angel | Jun 29, 2021 |
Shanghai CirCode Biomed Co. Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Pre Seed, Angel |
| Kunlun Capital | Pre Seed, Angel |
| 险峰K2VC | Pre Seed |
| Efung Capital | Pre Seed, Angel |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
| Apricot Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2023
Led by Johnson & Johnson Innovation.
- Dec 16, 2021
Led by K2VC with participation from Efung Capital, Kaitai Capital, and Kunlun Capital.
Shanghai CirCode Biomed Co. Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai CirCode Biomed Co. Ltd.'s valuation, stock price, and market status.